about
Diabetes insipidus: The other diabetesSynthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry.Congenital toxoplasmosis presenting as central diabetes insipidus in an infant: a case report.The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.Design, synthesis and biological activity of new neurohypophyseal hormones analogues conformationally restricted in the N-terminal part of the molecule. Highly potent OT receptor antagonists.Nephroprotective Effect of Echinodorus macrophyllus Micheli on Gentamicin-Induced Nephrotoxicity in Rats.Antiproliferative Effects of Oxytocin and Desmopressin on Canine Mammary Cancer Cells.Medical management of nocturnal enuresis.Consequences of nocturia.Diabetes insipidus in children.Optimizing response to desmopressin in patients with monosymptomatic nocturnal enuresis.Effects of Food and Pharmaceutical Formulation on Desmopressin Pharmacokinetics in Children.Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia.Antiproliferative effect of 1-deamino-8-D-arginine vasopressin analogs on human breast cancer cells.Safety profile of desmopressin tablet for enuresis in a prospective study.Quality of life in the patients with central diabetes insipidus assessed by Nagasaki Diabetes Insipidus Questionnaire.Desmopressin lyophilisate for the treatment of central diabetes insipidus: first experience in very young infantsGender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.Design, synthesis and structure-activity relationship of new arginine vasopressin analogues containing proline derivatives in position 2.Desmopressin use in pediatric nocturnal enuresis patients: is there a sex difference in prescription patterns?Desmopressin acetate nasal spray for adults with nocturia.Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).3T renal (23)Na-MRI: effects of desmopressin in patients with central diabetes insipidus.Desmopressin duration of antidiuretic action in patients with central diabetes insipidus.Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis.Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.Desmopressin-Induced Severe Hyponatremia with Central Pontine Myelinolysis: A Case Report.
P2860
Q26767266-8C84D792-1E84-40A8-B762-1D2AC3D41BFEQ33852418-7007B86A-47A6-46F7-A4C8-10AE4790CD29Q35133027-EF1460B4-A45F-4450-BB89-158254FB4089Q35636438-786DFC0D-8777-4B94-9CE3-771EE03F71A8Q36095654-AC81F52A-982D-41FA-AE76-7F8E6025E83DQ36100651-B883363A-C29E-435D-9176-EA4713927551Q37531523-8EF70252-F3AF-412F-B1F7-FC7BAB8AC577Q37968333-A4788194-779D-44FB-BF59-D7FC3316BDB3Q38120589-FA84E8F8-5F81-4C80-84AB-CEC6546955A2Q38583605-2C995BD5-FC23-4CBC-8E6A-DD9F50DA5EF3Q38806593-99FB3873-822E-4E10-B9B0-D28F01E7359CQ38877206-9B2436C0-DAC9-484D-BE85-87C2F0CF3835Q39174592-E4C018E3-16CF-489B-873E-4BB13936A629Q39440666-072DB748-2DBA-46DE-857F-E2BDEBF06FB6Q41600990-3F269822-AF54-4668-AB76-D407DAA617B7Q41708071-9398781D-5AFC-4020-8D4F-CA0DB01397F4Q41964607-D8258113-93CA-4562-A059-0F8B757C832CQ45329229-7762A740-D6F0-4657-98D9-AE3F5EA5B228Q45351370-43DC1558-D274-455D-82D8-C082BB93E92FQ47279090-9C0C553E-B267-44ED-B3D3-E6391D0EB6F8Q47630484-C4F72DA1-F16C-41D1-A380-D68E0241FECCQ48035948-39E5D62E-76E6-4577-8DEE-4374C68BF60BQ48093335-F72B091D-1894-48BF-BD4E-3EC67C1FD79DQ48133263-C2F53C04-6D84-4911-A65B-04D2D5F3CE6EQ49114906-64AB72C6-B210-4AF4-B32E-6DDBDFF1A17BQ50611571-292A20BF-2D35-4859-AFC1-F79018893318Q52562285-40D982C0-47B2-44DF-A670-6B568373C636
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Desmopressin 30 years in clinical use: a safety review.
@en
Desmopressin 30 years in clinical use: a safety review.
@nl
type
label
Desmopressin 30 years in clinical use: a safety review.
@en
Desmopressin 30 years in clinical use: a safety review.
@nl
prefLabel
Desmopressin 30 years in clinical use: a safety review.
@en
Desmopressin 30 years in clinical use: a safety review.
@nl
P2093
P1433
P1476
Desmopressin 30 years in clinical use: a safety review.
@en
P2093
Jens P Nørgaard
Johan Vande Walle
Mette Stockner
P304
P356
10.2174/157488607781668891
P577
2007-09-01T00:00:00Z